Heron Therapeutics
HRTX
#8229
Rank
$0.24 B
Marketcap
$1.33
Share price
-1.48%
Change (1 day)
-24.00%
Change (1 year)

Heron Therapeutics (HRTX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $0.23 Billion USD

According to Heron Therapeutics's latest financial reports the company's total liabilities are $0.23 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Heron Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$0.26 B4.02%
2023-12-31$0.25 B8.05%
2022-12-31$0.23 B4.05%
2021-12-31$0.22 B94.88%
2020-12-31$0.11 B7.45%
2019-12-31$0.10 B18.4%
2018-12-31$92.01 M-10.81%
2017-12-31$0.10 B16.27%
2016-12-31$88.73 M349.62%
2015-12-31$19.73 M44.9%
2014-12-31$13.62 M94.79%
2013-12-31$6.99 M68.32%
2012-12-31$4.15 M12.48%
2011-12-31$3.69 M131.54%
2010-12-31$1.59 M-25.99%
2009-12-31$2.15 M-48.71%
2008-12-31$4.2 M-43.79%
2007-12-31$7.47 M43.99%
2006-12-31$5.19 M87.71%
2005-12-31$2.76 M-3.29%
2004-12-31$2.86 M51.16%
2003-12-31$1.89 M-18.52%
2002-12-31$2.32 M-46.44%
2001-12-31$4.33 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Alkermes
ALKS
$0.59 B 154.66%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
$0.57 B 143.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
$0.21 B-7.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$0.52 B 124.98%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
$58.51 M-75.00%๐Ÿ‡บ๐Ÿ‡ธ USA